Building a Sustainable Blueprint for a Holistic Market Access Strategy
Innovation in the pharma/life sciences arena has brought a shift toward targeted, often high-cost therapies aimed at smaller patient populations. These therapies require a comprehensive, unified market access strategy to ensure access for patients and to optimize brand success.
In this latest article, Ellen Cappellino, SVP, Market Access & Patient Services for EVERSANA, discusses how to integrate people, technology, real-world data and infrastructure to develop market access strategies that address:
Offered Free by: EVERSANA
See All Resources from: EVERSANA
This download should complete shortly. If the resource doesn't automatically download, please, click here.